From research to enterprise: Ars Bionica joins e-Novia’s Venture Studio
Ars Bionica joins the e-Novia ecosystem, marking a new step in the journey from scientific research to industrial venture creation.
The comp...
Ars Bionica joins the e-Novia ecosystem, marking a new step in the journey from scientific research to industrial venture creation.
The company builds on more than a decade of research conducted by the Rehab Technologies Lab, a joint initiative between the Istituto Italiano di Tecnologia and INAIL, recognized for its work in advanced prosthetics. On this foundation, Ars Bionica pursues a clear ambition: to improve people’s quality of life through next-generation prosthetic devices that are reliable, accessible, and designed around real user needs.
Within this context, Ars Bionica’s entry into e-Novia’s Venture Studio represents a key step in accelerating its development. The focus is on moving the technology beyond the research phase and advancing its path toward industrialization and market adoption.
The joint effort between Ars Bionica‘s co-founders and the e-Novia team will concentrate on this transition, turning scientific potential into a scalable product. This requires a combination of capabilities, spanning technology development, product engineering, and the establishment of strategic partnerships to enable industrial validation and market access. This is where the e-Novia Venture Studio operates, working alongside founders to build robust and sustainable companies.
In the case of Ars Bionica, this means accelerating the transformation of research-based solutions into new benchmarks for the prosthetics sector, with a direct impact on patients’ quality of life and on the sustainability of healthcare systems.
Throughout this growth journey, the Venture Studio goes beyond supporting startup development. It contributes to shaping industrial positioning and defining the development model, working from the earliest stages alongside researchers, entrepreneurs, and technology partners.
Ars Bionica is a clear example of this approach: a technology grounded in strong scientific research that is now entering a market-oriented development phase, with the ambition to deliver tangible impact on people’s lives.
